Literature DB >> 15338156

[Substance abuse in middle and old age -- general abuse].

K U Ettrich1, A Fischer-Cyrulies.   

Abstract

The problems of drug-addicted middle- and older-aged people have been disregarded for a long time. However, results show a risky consumption of illegal drugs in the 18- to 59-year-old German population. The following paper will analyse the substance abuse of alcohol, sedatives, cannabis, stimulants, cocaine, opiates and other drugs not described more closely (all of which lead to health problems) using the Interdisciplinary Longitudinal Study of Adulthood (ILSE). Data collection is based on two cohorts (1930-1932 and 1950-1952) at two measurement points (1. MMP: N = 1006, 2. MMP: N = 900) in centres of investigation in Heidelberg and Leipzig. The "Substance Abuse Section" of the Structured Clinical Interview for DSM-III-R (SCID) was used for the evaluation. The abuse of alcohol can be registered as the focal point. Men consume more alcohol, while women tend to take sedatives, stimulants, opiates and other substances more often. The East-West comparison shows the importance of accessibility. At both measurement points, abuse of more substance groups was determined in the Heidelberg centre. As for as the abuse rates are concerned, a reduction of all the substance groups can be registered for the second measurement point.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338156     DOI: 10.1007/s00391-004-0244-z

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  1 in total

1.  Alcoholism and prescription drug abuse in the elderly: St. Louis University grand rounds.

Authors:  K Solomon; J Manepalli; G A Ireland; G M Mahon
Journal:  J Am Geriatr Soc       Date:  1993-01       Impact factor: 5.562

  1 in total
  1 in total

1.  [Substance abuse in middle and old age-everyday drug alcohol and nicotine: use and abuse].

Authors:  K U Ettrich; A Fischer-Cyrulies
Journal:  Z Gerontol Geriatr       Date:  2005-02       Impact factor: 1.281

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.